期刊文献+

Delta晶型甘露醇经物理改性后在口服固体制剂中的应用研究

Application of Delta-mannitol in Oral Solid Preparations after Physical Modification
下载PDF
导出
摘要 对Delta-甘露醇在湿法制粒过程中发生物理改性的特性进行研究。用纯化水诱导Delta-甘露醇物理性质发生改变,采用XRPD、SEM进行表征;并载药布洛芬,设计不同处方进行压片试验,评价其片剂性能。在液体L/S为20%~30%时,XRPD表明Delta-甘露醇发生晶型转变,同时制备的颗粒紧实、致密;SEM显示Delta-甘露醇发生片状结构到微晶结构的形态学转变;在使用相同量甘露醇的片剂处方中,Delta-片具有更大的孔容积和比表面积;Delta-片的抗张强度明显高于Beta-片,Delta-片在60 min时累积溶出率高,且崩解时间短。Delta-甘露醇经水分诱导发生物理改性,对提高片剂的压缩性能有突出作用,同时也改善了片剂其它性能。 The characteristics of physical modification of delta mannitol in wet granulation were studied.The physical properties of delta mannitol were changed by purified water and characterized by XRPD and SEM;Different formulations of ibuprofen were designed for tablet compression test to evaluate its tablet performance.When the liquid L/S is 20% ~ 30%,XRPD shows that the crystal form of delta mannitol changes,and the prepared particles are compact and compact;SEM showed that the morphology of delta mannitol changed from flake structure to microcrystalline structure;In the tablet formulation using the same amount of mannitol,delta tablets have larger pore volume and specific surface area;The tensile strength of delta tablets was significantly higher than that of beta tablets.Delta tablets had high cumulative dissolution rate and short disintegration time at 60 min.The physical modification of delta mannitol induced by water not only plays a prominent role in improving the compression properties of tablets,but also improves other properties of tablets.
作者 李国欣 顾王文 李珂珂 Li Guoxin;Gu Wangwen;Li Keke(School of pharmacy,Binzhou Medical College,Yantai 264000;Shanghai Institute of Material Medica Pharmaceutical Preparation Research Center,Chinese Academy of Sciences,Shanghai 201203,China)
出处 《广东化工》 CAS 2022年第13期44-46,28,共4页 Guangdong Chemical Industry
关键词 甘露醇 晶型转变 可压缩性 固体制剂 溶出 Mannitol crystal transformation compressibility solid preparations dissolution
  • 相关文献

参考文献3

二级参考文献25

  • 1许新德,姚善泾,邵斌.几种β-胡萝卜素微胶囊干粉的压缩特性和成型机理[J].化工学报,2007,58(2):452-459. 被引量:7
  • 2Jackson K, Young D, Pant S. Drug-excipient interactions and their affect on absorption [J]. Pharm Sci Technol Today, 2000, 3(10): 336-345.
  • 3Wandel C, Kim R B, Stein C M. "Inactive" excipients such as Cremophor can affect in vivo drug disposition [J]. Clin Pharmacol Ther, 2003, 73(5): 394-396.
  • 4Gohel M C, gani P D. review of co-processed directly compressible excipients [J]. J Pharm Sci, 2005, 8(1): 76-93.
  • 5IIija I, Peter K J, Rok D, et al. The compressibility andcompactibility of different types of lactose [J]. Drug Dev lndPharm, 2009, 35(10): 1271-1280.
  • 6Sonnergaard J M. Quantification of the compactibility of pharmaceutical powders [J]. Eur J Pharm Biopharm, 2006, 63(3): 270-277.
  • 7Wu C Y, Ruddy O M, Bentham A C, et al. Modeling the mechanical behaviour of pharmaceutical powders during compaction [J]. Powder Technol, 2005, 152(1/3):107-117.
  • 8Armstrong N A, Haines-Nutt R F. Elastic recovery and surface area changes in compacted powder systems [J]. Powder Technol, 1972, 9(5): 287-290.
  • 9Paronen P, Juslin M. Compressional characteristics of four starches [J]. J Pharm Pharmcol, 1983, 35(10): 627-635.
  • 10Marshall P V, York P. The compaction properties of nitrofurantion samples crystallized from different solvent [J]. Int JPharrn, 1991, 67(1): 59-65.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部